PAO4 COST ANALYSIS OF A 12-WEEK CYCLE OF THERAPY WITH CELECOXIB VS. CONVENTIONAL NSAIDS IN PATIENTS WITH OSTEOARTHRITIS
May 1, 2002, 00:00 AM
10.1016/S1098-3015(10)60956-4
https://www.valueinhealthjournal.com/article/S1098-3015(10)60956-4/fulltext
Section Title :
Section Order :
143
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)60956-4&doi=10.1016/S1098-3015(10)60956-4